Cargando…

106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES

BACKGROUND AND AIMS: G6PD deficiencies is a genetically issue that is noticed and is wide spread in our region and around the world. Despite the screening program for this disease since 2005 there are noticeable cases. METHODS: In this descriptive study the file of 923 patients that were diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarhani, Fariba, Dalvand, Shabnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759429/
http://dx.doi.org/10.1136/bmjopen-2016-015415.106
_version_ 1783291196704030720
author Tarhani, Fariba
Dalvand, Shabnam
author_facet Tarhani, Fariba
Dalvand, Shabnam
author_sort Tarhani, Fariba
collection PubMed
description BACKGROUND AND AIMS: G6PD deficiencies is a genetically issue that is noticed and is wide spread in our region and around the world. Despite the screening program for this disease since 2005 there are noticeable cases. METHODS: In this descriptive study the file of 923 patients that were diagnosed with Favism and hospitalized in Khorramabad hospitals during 2005 and 2015 were reviewed. This information includes the number of occurrence for each year, the causes of new cases which analyzed and recorded. CONCLUSION: Even so the cases reduced from 102 at 2005 to 33 at 2015 (60% reduction) but the most case were on 2009 and 2013 with 102 case and 145 case respectively. The cause of developing of these case is under observation and consideration. The most noticeable causes of occurrences are misunderstanding of the parents from permanent nature of disease (63.0%), neglecting disease (12.0%), Lack of providing of screening results to parents (12.0%) and use of Oxidant agents without parental supervision (8.0%), use of wrong Oxidant medication (5.0%). Despite of large expenses for screening program it seems that educate and providing information to the parents needs revision.
format Online
Article
Text
id pubmed-5759429
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57594292018-02-12 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES Tarhani, Fariba Dalvand, Shabnam BMJ Open Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira BACKGROUND AND AIMS: G6PD deficiencies is a genetically issue that is noticed and is wide spread in our region and around the world. Despite the screening program for this disease since 2005 there are noticeable cases. METHODS: In this descriptive study the file of 923 patients that were diagnosed with Favism and hospitalized in Khorramabad hospitals during 2005 and 2015 were reviewed. This information includes the number of occurrence for each year, the causes of new cases which analyzed and recorded. CONCLUSION: Even so the cases reduced from 102 at 2005 to 33 at 2015 (60% reduction) but the most case were on 2009 and 2013 with 102 case and 145 case respectively. The cause of developing of these case is under observation and consideration. The most noticeable causes of occurrences are misunderstanding of the parents from permanent nature of disease (63.0%), neglecting disease (12.0%), Lack of providing of screening results to parents (12.0%) and use of Oxidant agents without parental supervision (8.0%), use of wrong Oxidant medication (5.0%). Despite of large expenses for screening program it seems that educate and providing information to the parents needs revision. BMJ Publishing Group 2017-02-08 /pmc/articles/PMC5759429/ http://dx.doi.org/10.1136/bmjopen-2016-015415.106 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
Tarhani, Fariba
Dalvand, Shabnam
106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
title 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
title_full 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
title_fullStr 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
title_full_unstemmed 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
title_short 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
title_sort 106: review of screening program effect on incidence of hemolytic disease due to g6pd deficiencies
topic Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759429/
http://dx.doi.org/10.1136/bmjopen-2016-015415.106
work_keys_str_mv AT tarhanifariba 106reviewofscreeningprogrameffectonincidenceofhemolyticdiseaseduetog6pddeficiencies
AT dalvandshabnam 106reviewofscreeningprogrameffectonincidenceofhemolyticdiseaseduetog6pddeficiencies